Yi Q - Search Results

1

Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells.

Wen YJ, Barlogie B, Yi Q. Wen YJ, et al. Among authors: yi q. Blood. 2001 Mar 15;97(6):1750-5. doi: 10.1182/blood.v97.6.1750. Blood. 2001. PMID: 11238117 Free article.

2

Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies.

Yi Q, Osterborg A, Bergenbrant S, Mellstedt H, Holm G, Lefvert AK. Yi Q, et al. Blood. 1995 Oct 15;86(8):3043-9. Blood. 1995. PMID: 7579398 Free article.

3

Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells.

Yi Q, Dabadghao S, Osterborg A, Bergenbrant S, Holm G. Yi Q, et al. Blood. 1997 Sep 1;90(5):1960-7. Blood. 1997. PMID: 9292530 Free article.

4

Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses.

Osterborg A, Yi Q, Henriksson L, Fagerberg J, Bergenbrant S, Jeddi-Tehrani M, Rudén U, Lefvert AK, Holm G, Mellstedt H. Osterborg A, et al. Among authors: yi q. Blood. 1998 Apr 1;91(7):2459-66. Blood. 1998. PMID: 9516146 Free article. Clinical Trial.

5

Blood dendritic cells from myeloma patients are not infected with Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8).

Yi Q, Ekman M, Anton D, Bergenbrant S, Osterborg A, Georgii-Hemming P, Holm G, Nilsson K, Biberfeld P. Yi Q, et al. Blood. 1998 Jul 15;92(2):402-4. Blood. 1998. PMID: 9657737 Free article.

6

Myeloma-reactive allospecific cytotoxic T lymphocytes lyse target cells via the granule exocytosis pathway.

Chiriva-Internati M, Du J, Cannon M, Barlogie B, Yi Q. Chiriva-Internati M, et al. Among authors: yi q. Br J Haematol. 2001 Feb;112(2):410-20. doi: 10.1046/j.1365-2141.2001.02531.x. Br J Haematol. 2001. PMID: 11167840 Free article.

7

Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy.

Wen YJ, Min R, Tricot G, Barlogie B, Yi Q. Wen YJ, et al. Among authors: yi q. Blood. 2002 May 1;99(9):3280-5. doi: 10.1182/blood.v99.9.3280. Blood. 2002. PMID: 11964294 Free article.

8

Optimizing dendritic cell-based immunotherapy in multiple myeloma.

Yi Q, Desikan R, Barlogie B, Munshi N. Yi Q, et al. Br J Haematol. 2002 May;117(2):297-305. doi: 10.1046/j.1365-2141.2002.03411.x. Br J Haematol. 2002. PMID: 11972511 Free article.

9

Beta(2)-microglobulin as a negative growth regulator of myeloma cells.

Min R, Li Z, Epstein J, Barlogie B, Yi Q. Min R, et al. Among authors: yi q. Br J Haematol. 2002 Aug;118(2):495-505. doi: 10.1046/j.1365-2141.2002.03635.x. Br J Haematol. 2002. PMID: 12139738 Free article.

10

Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells.

Xie J, Wang Y, Freeman ME 3rd, Barlogie B, Yi Q. Xie J, et al. Among authors: yi q. Blood. 2003 May 15;101(10):4005-12. doi: 10.1182/blood-2002-11-3368. Epub 2003 Jan 16. Blood. 2003. PMID: 12531797 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,728 results

Search Page

Filters